Article translated into Italian. Below in the original English language.
Within its preventive parametric quantity, a certain degree of freedom is given in the formulation of national policies given to the parts of the world organization of drug management. Like most multilateral instruments, the conventions of the past are the product of a political compromise that makes their interpretation more of an art than a science. An elaborate guide to the interpretation is disclosed for each written agreement in a political commentary on the law. The proceedings of the conferences concerning the intentions and arguments used in the debates to be successful are compromised and end up affecting the final choice of words to be used. The instructive observation of the parties is another supply necessary to determine the margins of delivery of uncertain terms. The versatile interpretations of the clauses of the written agreement of the parties not challenged over time become a part of the accepted reading scope.
Resolutions or political statements adopted by most ofGeneral Assembly they can also play a significant role in this sense. Finally, in its ability to observe compliance, the Control Commission collectively advises countries on the implementation and delivery of the last three conventions. Typically, the commission retains the minimum act of representing the agreement and generally delays the development and acceptance of legal arguments bound by the parties, however, it is not responsible for resolving or reaching agreement on the dispute once changes occur. exhibit.
All these combined sources provide indications for what constitutes an interpretation of the terms of the treaty in their context as required by treaty law. The resulting definitions provided the existing flexibility that led to a variety of cannabis policy practices and reforms that deviate from a repressive approach.
An article of the Convention specifies that the treaty does not apply to the cultivation of the cannabis plant for industrial purposes both for seeds and for hemp plants grown for agricultural purposes (fiber, seed, horticulture). The practice of cannabis for recreational purposes remains prohibited in most countries; nevertheless, several countries have declared a system of decriminalization to make non-crime possession simple, often compared to a not too significant fine. The forms of the cannabis plant with approximately minimum psychoactive cannabinoid content generally incorporated as cannabis rather than cannabis, have been widely used for its fiber to make paper, denim or sails. The legal hemp industry has suffered greatly from controls imposed on marijuana, but is experiencing a return. The treaty has explicitly left open the use of cannabis for such purposes, but has posed operational problems for law enforcement as both types of plants have the same appearance as cannabis, marijuana and cannabis and a gray market for marijuana to high content of THC as the popular purple haze e bruce banner seeds sold for recreational purposes in some countries.
There is no uncertainty that the conventions of the world organizations, in theory, leave the medical use of controlled substances, as well as cannabis, and are intended to ensure sufficient maneuverability of the controlled medicine for the licit functions. The inclusion, however, of marijuana and its active ingredients in the strictest patterns of past treaties, keeps cannabis among substances with particularly dangerous properties that are not compensated by substantial therapeutic benefits, and this has created obstacles to the legal provisions for medical use of cannabis. The control committee has often expressed its opposition to medical marijuana patterns comparable to those operating at the state level within the United States of America, one of its arguments is often disputed; the opposite, however, seems to possess extensive legal legitimacy. First of all, the Council questions the medical quality of marijuana. In the past the report observes that the conventions leave to the parties the interpretation of medical and scientific purposes, a vital goal, which allows the latitude within the meetings. The Council places the burden on governments not to allow its medical use unless the conclusive results of the analysis are accessible indicating its therapeutic usefulness. It is not up to the Council to decide whether scientific results are convincing or not, or whether or not cannabis has medical quality. A single decree has provided health organizations with recommendations on proper planning under the previous Conventions. However, there are several examples of positive results in the therapeutic use of cannabis.
The opposition of the Council for reasons of medical quality is unfounded for two reasons. Firstly, the lack of any universally accepted position on the matter and is not within the mandate or the competence of the commissions. Furthermore, the health organizations, as mentioned above, took a contradictory stance in its recommendations concerning the psychoactive substance or THC from seeds of high-THC strains of the previous Convention. The second purpose of the Board's rivalry is, however, more valid. As noted in its latest report, the Board of Directors also considers violations of restricted medical marijuana programs that establish the specific needs that a government should meet if it wants to allow the cultivation and cultivation of cannabis, as well as the establishment of an agency national cannabis plant to all growers of medical cannabis seeds should deliver their entire crops. The cultivation and distribution of green crack seeds from the medical cannabis seed bank for medicinal functions they are merely admissible under the strict management of the state and need to be growers authorized by the Agency with the exclusive right to trade, export, wholesale and stockpile. The Convention continues that wherever medical marijuana patterns are in place, an agency should assign all licenses and take physical possession of all crops. Most countries that allow medical cannabis practices have introduced and comply with the specified facilities and procedures. However, this may not be the case within operational business schemes in some cities or states, and therefore the Board's arguments concerning the legitimacy of these practices under the Conventions are legitimate.
Natalie Gray is a biochemical engineer. He works in the Research and Development team that deals with the design and construction of unitary processes. She is an avid supporter of marijuana and her love of organic chemistry has led her to medical cannabis. He grows his flowers, works on different projects and studies cannabis plants from the roots to the tops.
THE UPS AND DOWNS OF CANNABIS RESTRICTIONS